Cancer prevention videos and webinars related to DCP programs.
-
In this kick-off webinar, Dr. Patricia A. Ganz provided a keynote address on the state of symptom science research.
-
Please join the NCI Division of Cancer Prevention Immunology Interest Group (DCP IIG) seminar series talk focused on cancer prevention, interception, and immuno-oncology.
-
This pre-application webinar took place on November 9, 2023. NCI staff members involved in managing this program explained the goals and objectives of this initiative and answered questions from attendees. View the webinar meeting materials (Meeting Recordings & Slides).
-
Robert H. Vonderheide, M.D., D.Phil., is Director of the Abramson Cancer Center, Vice Dean of Cancer Programs for the Perelman School of Medicine, and Vice President for Cancer Programs at the University of Pennsylvania Health System.
-
The Discovery and Development of Natural Products for Cancer Interception and Prevention Program (DDNP-CIP) supports the discovery and development of new natural products that are safe, non-toxic, and efficacious for cancer interception and prevention.
-
To invite developers of Multi-Cancer Detection (MCD) Assays to partner with NCI and have their assays considered for the new Vanguard Study
-
Cancer treatment-related cardiotoxicity is a leading cause of treatment-associated morbidity and mortality in cancer survivors. The gaps in knowledge related to cardiotoxicity are large, including mechanisms of cardiac injury, clinical risk…
-
This is the 6th Virtual Joint Meeting of the National Cancer Advisory Board and the NCI Board of Scientific Advisors, scheduled for 3 days, 13-15 June 2022. 3rd Day - 15 June, Full Virtual Board Meeting, from 1:00 p.m. to 5:00 p.m.
-
The Helping to End Addiction Long-term (HEAL) Initiative is a trans-agency effort to address the opioid crisis. One aim of the HEAL Initiative focuses on addressing the crisis by developing better pain management research, techniques, and practices.
-
PAR 21-330: Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)